bio2004 conference

Solbec Pharmaceuticals Ltd
Pavilion: AUSTRALIA
Stephen Carter
PO Box 2142, CHURCHLANDS
PERTH, W A 6018, AUSTRALIA
P:61 8 9446 7555
F:61 8 9446 8777
W: www.solbec.com.au
Solbec Pharmaceuticals is a biotechnology company committed to the development and commercialisation of better therapies for life threatening and debilitating diseases. The current focus of Solbec is on the treatment of cancer, in particular melanoma and malignant mesothelioma. We are also focused on the treatment of the inflammatory dermal disorder psoriasis. These projects are based on our platform glycoalkaloid technology. This technology has been proved by the company to be an effective anti tumour agent and has potential anti-inflammatory activity. The drug appears to have a triple whammy approach to the treatment of cancer and our research supports a unique and previously unknown mode of action of the drug.

Found this in the list of presenters for the bio2004 conference in San Francisco . This is a very upbeat intro . One can only speculate what info they have to present .